The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TGODF) Stock Competitors & Peer Comparison
See (TGODF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TGODF | $0.29 | +1.79% | 0 | N/A | N/A | N/A |
| IPSEY | $46.30 | +5.21% | 61.2B | 30.06 | $1.54 | +0.86% |
| MKKGY | $25.52 | +4.76% | 54.8B | 18.12 | $1.39 | +2.00% |
| TKPHF | $34.52 | +0.00% | 54.5B | 78.45 | $0.44 | +3.39% |
| MKGAF | $131.08 | +2.60% | 53.2B | 17.63 | $6.94 | +2.04% |
| HLNCF | $4.98 | +1.22% | 44.3B | 19.92 | $0.25 | +1.84% |
| SDZNY | $80.63 | +6.68% | 33.8B | 37.35 | $2.09 | +0.94% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $23.60 | +10.02% | 20.1B | 18.73 | $1.26 | +1.64% |
| SGIOY | $11.42 | +5.04% | 18.8B | 17.51 | $0.63 | +1.82% |
Stock Comparison
TGODF vs IPSEY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, IPSEY has a market cap of 61.2B. Regarding current trading prices, TGODF is priced at $0.29, while IPSEY trades at $46.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 30.06. In terms of profitability, TGODF's ROE is N/A, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, TGODF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check IPSEY's competition here
TGODF vs MKKGY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, MKKGY has a market cap of 54.8B. Regarding current trading prices, TGODF is priced at $0.29, while MKKGY trades at $25.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 18.12. In terms of profitability, TGODF's ROE is N/A, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, TGODF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check MKKGY's competition here
TGODF vs TKPHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, TKPHF has a market cap of 54.5B. Regarding current trading prices, TGODF is priced at $0.29, while TKPHF trades at $34.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 78.45. In terms of profitability, TGODF's ROE is N/A, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, TGODF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check TKPHF's competition here
TGODF vs MKGAF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, MKGAF has a market cap of 53.2B. Regarding current trading prices, TGODF is priced at $0.29, while MKGAF trades at $131.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 17.63. In terms of profitability, TGODF's ROE is N/A, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, TGODF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check MKGAF's competition here
TGODF vs HLNCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HLNCF has a market cap of 44.3B. Regarding current trading prices, TGODF is priced at $0.29, while HLNCF trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 19.92. In terms of profitability, TGODF's ROE is N/A, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, TGODF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check HLNCF's competition here
TGODF vs SDZNY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SDZNY has a market cap of 33.8B. Regarding current trading prices, TGODF is priced at $0.29, while SDZNY trades at $80.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is 37.35. In terms of profitability, TGODF's ROE is N/A, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, TGODF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check SDZNY's competition here
TGODF vs TEVJF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, TGODF is priced at $0.29, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, TGODF's ROE is N/A, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, TGODF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check TEVJF's competition here
TGODF vs SGIOF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SGIOF has a market cap of 20.1B. Regarding current trading prices, TGODF is priced at $0.29, while SGIOF trades at $23.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 18.73. In terms of profitability, TGODF's ROE is N/A, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, TGODF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check SGIOF's competition here
TGODF vs SGIOY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SGIOY has a market cap of 18.8B. Regarding current trading prices, TGODF is priced at $0.29, while SGIOY trades at $11.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 17.51. In terms of profitability, TGODF's ROE is N/A, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, TGODF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check SGIOY's competition here
TGODF vs TAIPY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, TGODF is priced at $0.29, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, TGODF's ROE is N/A, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, TGODF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check TAIPY's competition here
TGODF vs ESALY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, TGODF is priced at $0.29, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, TGODF's ROE is N/A, compared to ESALY's ROE of +0.06%. Regarding short-term risk, TGODF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check ESALY's competition here
TGODF vs BIOVF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, BIOVF has a market cap of 13.8B. Regarding current trading prices, TGODF is priced at $0.29, while BIOVF trades at $39.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 284.79. In terms of profitability, TGODF's ROE is N/A, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, TGODF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check BIOVF's competition here
TGODF vs IPSEF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, TGODF is priced at $0.29, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, TGODF's ROE is N/A, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, TGODF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check IPSEF's competition here
TGODF vs ESAIY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ESAIY has a market cap of 8.9B. Regarding current trading prices, TGODF is priced at $0.29, while ESAIY trades at $8.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 28.81. In terms of profitability, TGODF's ROE is N/A, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, TGODF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check ESAIY's competition here
TGODF vs ESALF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ESALF has a market cap of 8.5B. Regarding current trading prices, TGODF is priced at $0.29, while ESALF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 27.27. In terms of profitability, TGODF's ROE is N/A, compared to ESALF's ROE of +0.05%. Regarding short-term risk, TGODF is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check ESALF's competition here
TGODF vs SFOSF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SFOSF has a market cap of 7.1B. Regarding current trading prices, TGODF is priced at $0.29, while SFOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 15.00. In terms of profitability, TGODF's ROE is N/A, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, TGODF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check SFOSF's competition here
TGODF vs GZPHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, TGODF is priced at $0.29, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, TGODF's ROE is N/A, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, TGODF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check GZPHF's competition here
TGODF vs LVZPF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, TGODF is priced at $0.29, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, TGODF's ROE is N/A, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, TGODF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check LVZPF's competition here
TGODF vs DNPUF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, DNPUF has a market cap of 5.4B. Regarding current trading prices, TGODF is priced at $0.29, while DNPUF trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 5.57. In terms of profitability, TGODF's ROE is N/A, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, TGODF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check DNPUF's competition here
TGODF vs HLBBF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HLBBF has a market cap of 4.9B. Regarding current trading prices, TGODF is priced at $0.29, while HLBBF trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 12.11. In terms of profitability, TGODF's ROE is N/A, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, TGODF is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check HLBBF's competition here
TGODF vs SMDPY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SMDPY has a market cap of 4.8B. Regarding current trading prices, TGODF is priced at $0.29, while SMDPY trades at $14.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 4.97. In terms of profitability, TGODF's ROE is N/A, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, TGODF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check SMDPY's competition here
TGODF vs HLUBF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, TGODF is priced at $0.29, while HLUBF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 9.64. In terms of profitability, TGODF's ROE is N/A, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, TGODF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check HLUBF's competition here
TGODF vs SGFEF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, TGODF is priced at $0.29, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 20.62. In terms of profitability, TGODF's ROE is N/A, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, TGODF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check SGFEF's competition here
TGODF vs HKMPF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HKMPF has a market cap of 3.8B. Regarding current trading prices, TGODF is priced at $0.29, while HKMPF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 9.56. In terms of profitability, TGODF's ROE is N/A, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, TGODF is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check HKMPF's competition here
TGODF vs HKMPY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HKMPY has a market cap of 3.7B. Regarding current trading prices, TGODF is priced at $0.29, while HKMPY trades at $33.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 9.18. In terms of profitability, TGODF's ROE is N/A, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, TGODF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check HKMPY's competition here
TGODF vs APNHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, TGODF is priced at $0.29, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is -34.17. In terms of profitability, TGODF's ROE is N/A, compared to APNHF's ROE of -0.02%. Regarding short-term risk, TGODF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check APNHF's competition here
TGODF vs APNHY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, APNHY has a market cap of 3.5B. Regarding current trading prices, TGODF is priced at $0.29, while APNHY trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is -32.37. In terms of profitability, TGODF's ROE is N/A, compared to APNHY's ROE of -0.02%. Regarding short-term risk, TGODF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check APNHY's competition here
TGODF vs LBTSF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, TGODF is priced at $0.29, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 61.40. In terms of profitability, TGODF's ROE is N/A, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, TGODF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check LBTSF's competition here
TGODF vs CHSYF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, TGODF is priced at $0.29, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, TGODF's ROE is N/A, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, TGODF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check CHSYF's competition here
TGODF vs INVVY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, TGODF is priced at $0.29, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, TGODF's ROE is N/A, compared to INVVY's ROE of -0.99%. Regarding short-term risk, TGODF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check INVVY's competition here
TGODF vs HYPMY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, TGODF is priced at $0.29, while HYPMY trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 12.17. In terms of profitability, TGODF's ROE is N/A, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, TGODF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check HYPMY's competition here
TGODF vs IZQVF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, TGODF is priced at $0.29, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, TGODF's ROE is N/A, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, TGODF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check IZQVF's competition here
TGODF vs DMPHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, DMPHF has a market cap of 2.6B. Regarding current trading prices, TGODF is priced at $0.29, while DMPHF trades at $48.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 21.99. In terms of profitability, TGODF's ROE is N/A, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, TGODF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check DMPHF's competition here
TGODF vs ULIHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, TGODF is priced at $0.29, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, TGODF's ROE is N/A, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, TGODF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check ULIHF's competition here
TGODF vs HMDCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, TGODF is priced at $0.29, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, TGODF's ROE is N/A, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, TGODF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check HMDCF's competition here
TGODF vs NPNKF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, TGODF is priced at $0.29, while NPNKF trades at $32.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 10.77. In terms of profitability, TGODF's ROE is N/A, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, TGODF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check NPNKF's competition here
TGODF vs HTSUF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, TGODF is priced at $0.29, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, TGODF's ROE is N/A, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, TGODF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check HTSUF's competition here
TGODF vs NPPNY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, NPPNY has a market cap of 2B. Regarding current trading prices, TGODF is priced at $0.29, while NPPNY trades at $7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 10.00. In terms of profitability, TGODF's ROE is N/A, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, TGODF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check NPPNY's competition here
TGODF vs ARSUF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, TGODF is priced at $0.29, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 18.88. In terms of profitability, TGODF's ROE is N/A, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, TGODF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check ARSUF's competition here
TGODF vs DUTV Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, TGODF is priced at $0.29, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas DUTV's P/E ratio is N/A. In terms of profitability, TGODF's ROE is N/A, compared to DUTV's ROE of -0.04%. Regarding short-term risk, TGODF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check DUTV's competition here
TGODF vs TSMRF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, TGODF is priced at $0.29, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, TGODF's ROE is N/A, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, TGODF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check TSMRF's competition here
TGODF vs SHPHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, TGODF is priced at $0.29, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, TGODF's ROE is N/A, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, TGODF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check SHPHF's competition here
TGODF vs CURLF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CURLF has a market cap of 1.7B. Regarding current trading prices, TGODF is priced at $0.29, while CURLF trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -6.72. In terms of profitability, TGODF's ROE is N/A, compared to CURLF's ROE of -0.29%. Regarding short-term risk, TGODF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check CURLF's competition here
TGODF vs MITPF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, TGODF is priced at $0.29, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, TGODF's ROE is N/A, compared to MITPF's ROE of +4.99%. Regarding short-term risk, TGODF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check MITPF's competition here
TGODF vs KARBF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, TGODF is priced at $0.29, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, TGODF's ROE is N/A, compared to KARBF's ROE of N/A. Regarding short-term risk, TGODF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check KARBF's competition here
TGODF vs GTBIF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, GTBIF has a market cap of 1.5B. Regarding current trading prices, TGODF is priced at $0.29, while GTBIF trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 13.23. In terms of profitability, TGODF's ROE is N/A, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, TGODF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check GTBIF's competition here
TGODF vs CHIZF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, TGODF is priced at $0.29, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, TGODF's ROE is N/A, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, TGODF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check CHIZF's competition here
TGODF vs CASBF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, TGODF is priced at $0.29, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -38.60. In terms of profitability, TGODF's ROE is N/A, compared to CASBF's ROE of +0.01%. Regarding short-term risk, TGODF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check CASBF's competition here
TGODF vs SWGHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, TGODF is priced at $0.29, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, TGODF's ROE is N/A, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, TGODF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check SWGHF's competition here
TGODF vs LJUIF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, TGODF is priced at $0.29, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, TGODF's ROE is N/A, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, TGODF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check LJUIF's competition here
TGODF vs TCNNF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, TCNNF has a market cap of 1.1B. Regarding current trading prices, TGODF is priced at $0.29, while TCNNF trades at $5.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -9.75. In terms of profitability, TGODF's ROE is N/A, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, TGODF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check TCNNF's competition here
TGODF vs BIOGY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, TGODF is priced at $0.29, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, TGODF's ROE is N/A, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, TGODF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check BIOGY's competition here
TGODF vs KSPHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, TGODF is priced at $0.29, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 11.99. In terms of profitability, TGODF's ROE is N/A, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, TGODF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check KSPHF's competition here
TGODF vs KKPCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, TGODF is priced at $0.29, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, TGODF's ROE is N/A, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, TGODF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check KKPCF's competition here
TGODF vs EVOTF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, EVOTF has a market cap of 931.2M. Regarding current trading prices, TGODF is priced at $0.29, while EVOTF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -5.04. In terms of profitability, TGODF's ROE is N/A, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, TGODF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check EVOTF's competition here
TGODF vs GNMLF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, GNMLF has a market cap of 886.9M. Regarding current trading prices, TGODF is priced at $0.29, while GNMLF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 10.12. In terms of profitability, TGODF's ROE is N/A, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, TGODF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check GNMLF's competition here
TGODF vs TWAPF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, TGODF is priced at $0.29, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, TGODF's ROE is N/A, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, TGODF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check TWAPF's competition here
TGODF vs CSWYF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, TGODF is priced at $0.29, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, TGODF's ROE is N/A, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, TGODF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check CSWYF's competition here
TGODF vs TRXPF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, TGODF is priced at $0.29, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, TGODF's ROE is N/A, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, TGODF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check TRXPF's competition here
TGODF vs SHEZF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, TGODF is priced at $0.29, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, TGODF's ROE is N/A, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, TGODF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check SHEZF's competition here
TGODF vs YIHCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, TGODF is priced at $0.29, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, TGODF's ROE is N/A, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, TGODF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check YIHCF's competition here
TGODF vs GLASF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, GLASF has a market cap of 639.5M. Regarding current trading prices, TGODF is priced at $0.29, while GLASF trades at $8.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -15.02. In terms of profitability, TGODF's ROE is N/A, compared to GLASF's ROE of -0.23%. Regarding short-term risk, TGODF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check GLASF's competition here
TGODF vs AIHLF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, TGODF is priced at $0.29, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, TGODF's ROE is N/A, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, TGODF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check AIHLF's competition here
TGODF vs TRSSF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, TGODF is priced at $0.29, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, TGODF's ROE is N/A, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, TGODF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check TRSSF's competition here
TGODF vs PKBFF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, TGODF is priced at $0.29, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, TGODF's ROE is N/A, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, TGODF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check PKBFF's competition here
TGODF vs KHTRF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, KHTRF has a market cap of 521.5M. Regarding current trading prices, TGODF is priced at $0.29, while KHTRF trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is -133.00. In terms of profitability, TGODF's ROE is N/A, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, TGODF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check KHTRF's competition here
TGODF vs CCHWF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, TGODF is priced at $0.29, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, TGODF's ROE is N/A, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, TGODF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check CCHWF's competition here
TGODF vs BOIRF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, TGODF is priced at $0.29, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, TGODF's ROE is N/A, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, TGODF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check BOIRF's competition here
TGODF vs AGYTF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, TGODF is priced at $0.29, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, TGODF's ROE is N/A, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, TGODF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check AGYTF's competition here
TGODF vs PEXXF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, TGODF is priced at $0.29, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, TGODF's ROE is N/A, compared to PEXXF's ROE of N/A. Regarding short-term risk, TGODF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check PEXXF's competition here
TGODF vs HUMDF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HUMDF has a market cap of 407.7M. Regarding current trading prices, TGODF is priced at $0.29, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is 2.58. In terms of profitability, TGODF's ROE is N/A, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, TGODF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check HUMDF's competition here
TGODF vs SWDCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SWDCF has a market cap of 399.6M. Regarding current trading prices, TGODF is priced at $0.29, while SWDCF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 62.50. In terms of profitability, TGODF's ROE is N/A, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, TGODF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check SWDCF's competition here
TGODF vs NIKA Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, NIKA has a market cap of 395.1M. Regarding current trading prices, TGODF is priced at $0.29, while NIKA trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, TGODF's ROE is N/A, compared to NIKA's ROE of +0.29%. Regarding short-term risk, TGODF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check NIKA's competition here
TGODF vs ELTP Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ELTP has a market cap of 390.3M. Regarding current trading prices, TGODF is priced at $0.29, while ELTP trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is 9.06. In terms of profitability, TGODF's ROE is N/A, compared to ELTP's ROE of +0.71%. Regarding short-term risk, TGODF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check ELTP's competition here
TGODF vs VRNOF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, VRNOF has a market cap of 365.4M. Regarding current trading prices, TGODF is priced at $0.29, while VRNOF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -1.02. In terms of profitability, TGODF's ROE is N/A, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, TGODF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check VRNOF's competition here
TGODF vs CPHRF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CPHRF has a market cap of 331.8M. Regarding current trading prices, TGODF is priced at $0.29, while CPHRF trades at $13.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 12.44. In terms of profitability, TGODF's ROE is N/A, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, TGODF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check CPHRF's competition here
TGODF vs CRLBF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CRLBF has a market cap of 305.5M. Regarding current trading prices, TGODF is priced at $0.29, while CRLBF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.34. In terms of profitability, TGODF's ROE is N/A, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, TGODF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check CRLBF's competition here
TGODF vs PROCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, PROCF has a market cap of 253.4M. Regarding current trading prices, TGODF is priced at $0.29, while PROCF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas PROCF's P/E ratio is 0.27. In terms of profitability, TGODF's ROE is N/A, compared to PROCF's ROE of -2.24%. Regarding short-term risk, TGODF is less volatile compared to PROCF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check PROCF's competition here
TGODF vs BHCCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, TGODF is priced at $0.29, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, TGODF's ROE is N/A, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, TGODF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check BHCCF's competition here
TGODF vs PLNHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, TGODF is priced at $0.29, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, TGODF's ROE is N/A, compared to PLNHF's ROE of +659479.06%. Regarding short-term risk, TGODF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check PLNHF's competition here
TGODF vs PHCUF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, TGODF is priced at $0.29, while PHCUF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, TGODF's ROE is N/A, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, TGODF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check PHCUF's competition here
TGODF vs COPHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, TGODF is priced at $0.29, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, TGODF's ROE is N/A, compared to COPHF's ROE of -5.75%. Regarding short-term risk, TGODF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check COPHF's competition here
TGODF vs LOVFF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, LOVFF has a market cap of 124.5M. Regarding current trading prices, TGODF is priced at $0.29, while LOVFF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 14.44. In terms of profitability, TGODF's ROE is N/A, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, TGODF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check LOVFF's competition here
TGODF vs NWPN Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, TGODF is priced at $0.29, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas NWPN's P/E ratio is -0.04. In terms of profitability, TGODF's ROE is N/A, compared to NWPN's ROE of +0.13%. Regarding short-term risk, TGODF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check NWPN's competition here
TGODF vs CBWTF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CBWTF has a market cap of 121.4M. Regarding current trading prices, TGODF is priced at $0.29, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 4.50. In terms of profitability, TGODF's ROE is N/A, compared to CBWTF's ROE of +0.27%. Regarding short-term risk, TGODF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check CBWTF's competition here
TGODF vs BIOYF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, BIOYF has a market cap of 118.5M. Regarding current trading prices, TGODF is priced at $0.29, while BIOYF trades at $10.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 18.40. In terms of profitability, TGODF's ROE is N/A, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, TGODF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check BIOYF's competition here
TGODF vs CWBHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CWBHF has a market cap of 117.2M. Regarding current trading prices, TGODF is priced at $0.29, while CWBHF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CWBHF's P/E ratio is -5.25. In terms of profitability, TGODF's ROE is N/A, compared to CWBHF's ROE of -2.75%. Regarding short-term risk, TGODF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check CWBHF's competition here
TGODF vs SHIEF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, SHIEF has a market cap of 114.7M. Regarding current trading prices, TGODF is priced at $0.29, while SHIEF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas SHIEF's P/E ratio is -5.37. In terms of profitability, TGODF's ROE is N/A, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, TGODF is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check SHIEF's competition here
TGODF vs LPCUF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, TGODF is priced at $0.29, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, TGODF's ROE is N/A, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, TGODF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check LPCUF's competition here
TGODF vs CNVCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, TGODF is priced at $0.29, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, TGODF's ROE is N/A, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, TGODF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check CNVCF's competition here
TGODF vs JUSHF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, JUSHF has a market cap of 102.8M. Regarding current trading prices, TGODF is priced at $0.29, while JUSHF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas JUSHF's P/E ratio is -1.58. In terms of profitability, TGODF's ROE is N/A, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, TGODF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check JUSHF's competition here
TGODF vs ORXOY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, TGODF is priced at $0.29, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ORXOY's P/E ratio is -2.26. In terms of profitability, TGODF's ROE is N/A, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, TGODF is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check ORXOY's competition here
TGODF vs AAWH Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, AAWH has a market cap of 97.1M. Regarding current trading prices, TGODF is priced at $0.29, while AAWH trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -0.83. In terms of profitability, TGODF's ROE is N/A, compared to AAWH's ROE of -14.10%. Regarding short-term risk, TGODF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check AAWH's competition here
TGODF vs ABSCF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, TGODF is priced at $0.29, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -8.53. In terms of profitability, TGODF's ROE is N/A, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, TGODF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check ABSCF's competition here
TGODF vs HLTRF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, HLTRF has a market cap of 93.8M. Regarding current trading prices, TGODF is priced at $0.29, while HLTRF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -7.69. In terms of profitability, TGODF's ROE is N/A, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, TGODF is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check HLTRF's competition here
TGODF vs ORXOF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, ORXOF has a market cap of 79.3M. Regarding current trading prices, TGODF is priced at $0.29, while ORXOF trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas ORXOF's P/E ratio is -1.84. In terms of profitability, TGODF's ROE is N/A, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, TGODF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check ORXOF's competition here
TGODF vs EOFBY Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, TGODF is priced at $0.29, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, TGODF's ROE is N/A, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, TGODF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check EOFBY's competition here
TGODF vs GRUSF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, GRUSF has a market cap of 73.6M. Regarding current trading prices, TGODF is priced at $0.29, while GRUSF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is 9.83. In terms of profitability, TGODF's ROE is N/A, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, TGODF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for TGODF.Check GRUSF's competition here
TGODF vs MEDXF Comparison April 2026
TGODF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGODF stands at 0. In comparison, MEDXF has a market cap of 72.4M. Regarding current trading prices, TGODF is priced at $0.29, while MEDXF trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGODF currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is -112.00. In terms of profitability, TGODF's ROE is N/A, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, TGODF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for TGODF.Check MEDXF's competition here